KMTS (KMTS) Stock Price & Analysis
KMTS (KMTS) rose 0.37% to USD 25.64 as of September 9, 2026 at 11:00 UTC, according to Nexqual real-time market data.
KMTS last closed at USD 25.64; the session ranged USD 24.87–25.79 on volume of 349,338 shares. Market capitalization is —, with a 52-week range of USD 17.34–30 (NMS). Source: Nexqual, September 9, 2026 at 11:00 UTC.
Key Statistics (as of September 9, 2026 at 11:00 UTC)
| Price | USD 25.64 |
|---|---|
| Change | ▲ 0.37% (up) |
| Previous Close | USD 25.64 |
| Open | USD 25.64 |
| Day Range | USD 24.87 – 25.79 |
| 52-Week Range | USD 17.34 – 30 |
| Volume | 349,338 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (KMTS)
Nexqual's technical model rates KMTS "NEUTRAL" based on 3 bullish and 2 bearish signals across 127 daily candles, as of September 9, 2026 at 11:00 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 54.39 (neutral) |
| vs SMA50 | Above (USD 25.5) |
| MACD | 0.04 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBNX | Beta Bionics, Inc. | USD 19.33 | ▼ 2.96% |
| CBLL | CeriBell, Inc. | USD 24.31 | ▼ 1.06% |
| CARL | Carlsmed, Inc. | USD 15.23 | ▼ 1.87% |
| HTFL | Heartflow, Inc. | USD 47.75 | ▼ 3.94% |
| MAZE | Maze Therapeutics, Inc. | USD 26.37 | ▲ 1.93% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 11:00 UTC. This page is informational and not investment advice.